Loss of PTEN expression is associated with aggressive behavior and poor prognosis in Middle Eastern triple-negative breast cancer. - Wikidata - wikimedia - TriplyDB

Loss of PTEN expression is associated with aggressive behavior and poor prognosis in Middle Eastern triple-negative breast cancer.

Loss of PTEN expression is associated with aggressive behavior and poor prognosis in Middle Eastern triple-negative breast cancer.

http://www.wikidata.org/entity/Q40931689

about

Current advances in biomarkers for targeted therapy in triple-negative breast cancer Loss of phosphatase and tensin homolog expression correlates with clinicopathological features of non-small cell lung cancer patients and its impact on survival: A systematic review and meta-analysis.Loss of PTEN expression in breast cancer: association with clinicopathological characteristics and prognosis.MicroRNAs in the prognosis of triple-negative breast cancer: A systematic review and meta-analysis The association of PTEN hypermethylation and breast cancer: a meta-analysis Downregulation of miR-221/222 by a microRNA sponge promotes apoptosis in oral squamous cell carcinoma cells through upregulation of PTEN.Predictive factors of the tumor immunological microenvironment for long-term follow-up in early stage breast cancer High expression of microRNA-454 is associated with poor prognosis in triple-negative breast cancer.Relationship between tumour PTEN/Akt/COX-2 expression, inflammatory response and survival in patients with colorectal cancer.Reciprocal regulation of Hsa-miR-1 and long noncoding RNA MALAT1 promotes triple-negative breast cancer development.Lentiviral-Mediated Short Hairpin RNA Knockdown of MTDH Inhibits Cell Growth and Induces Apoptosis by Regulating the PTEN/AKT Pathway in Hepatocellular Carcinoma Reply to specific gene patterns and molecular pathways related to human carcinogenesis in different populations among various geographic locations.FoxM1 is an independent poor prognostic marker and therapeutic target for advanced Middle Eastern breast cancer.Detection of PIK3/AKT pathway in Moroccan population with triple negative breast cancer

P2860

Q28074202-8710E293-7FA9-49EF-BF75-C63C764B59AB Q33633647-895FC33A-E648-404F-BED8-05D922AA9054 Q33762003-71B53994-37C0-4A97-9C0C-61E1A666201A Q33765619-B6602AE9-83AF-4E58-A418-6C61D23C47F7 Q37261822-A8B9DA5D-0047-48D8-A385-7165BED7DA48 Q37581748-95289698-7AA3-49F5-B686-6D62B123F51E Q37611683-38B88757-C482-43D6-A4C6-40236A083909 Q37662154-9059C87C-FDCC-475F-90CF-B63B1A4209FA Q37688583-0CDF8161-2709-444C-A3D9-04DC903BA1EF Q38811190-FB2C3912-645E-489B-9B35-924C4D31E779 Q41471356-D9E7AA27-5B2D-4445-977F-67D0A33BE674 Q53206785-97AEA7C0-7564-4151-932D-0ED0752584ED Q55287201-7ABB3265-6F6A-4BE6-85FC-5EFCAD27000F Q58725505-07746BFB-9C24-414B-B27E-A139937E3E08

P2860

Loss of PTEN expression is associated with aggressive behavior and poor prognosis in Middle Eastern triple-negative breast cancer.

http://www.wikidata.org/entity/Q40931689

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

Loss of PTEN expression is ass ...... triple-negative breast cancer.

@en

type

label

Loss of PTEN expression is ass ...... triple-negative breast cancer.

@en

prefLabel

Loss of PTEN expression is ass ...... triple-negative breast cancer.

@en

P1433

Q40931689-A403F67F-D3BE-4AE3-8F93-AD35DCBE0A38

P1476

Q40931689-37169BC2-90F5-439A-B489-C4CC0DC772B7

P2093

Q40931689-0036306A-5409-4705-917B-019E8E8A41C9

Q40931689-0726644D-667C-427E-AAE7-9EC212237904

Q40931689-15A6E489-045B-45EB-994D-C7F8F7D3688A

Q40931689-1C2EA1D1-220E-4CE0-9EA7-CE191857D9A3

Q40931689-50B507E1-CA48-425F-8DAD-1F24CED53E0B

Q40931689-569028A0-9D37-48C9-852F-3EF7388E158D

Q40931689-56C5880A-4096-4D95-BBA3-47C6AE74909D

P2860

Q40931689-2010038A-7FE9-40E7-BC9C-62092D4E7C22

Q40931689-21F4EB86-2E5F-4759-BA33-DF511B10DA9F

Q40931689-325FB58B-F687-4C78-A6AE-671A3B437C7D

Q40931689-327B7656-444C-4D4D-9023-374B18B7CBF0

Q40931689-4F2EAA62-3F85-4A71-81B4-04C79F1210D9

Q40931689-503D35A2-999A-4D7B-90D1-ED812BA63563

Q40931689-5C3A924A-D3DA-4D09-BC7F-FFD75636C9FB

Q40931689-5C4E5A34-31CE-4277-A052-CBB8C12794C2

Q40931689-8922BBA2-6DB9-4EB6-AAF5-05A864641FE6

Q40931689-8B324FD1-9FE9-4F05-9150-2F5A6F23BD07

P2888

Q40931689-DDFDCE10-2E96-4A82-A3A5-7B18A078A3B9

P304

Q40931689-39FB3232-3BA5-4AC5-B934-D3EDF4EF88A9

P31

Q40931689-5F7CC2B8-4A74-4DC9-962B-D38EB86CFB5B

P356

Q40931689-50AFF5F8-0E81-4B04-99A9-F0869D9E8F06

P407

Q40931689-DBCA242B-125F-4FF9-8A07-5520F95A8B5F

P433

Q40931689-565D2BA9-A7A4-4293-AF69-75834751C6A2

P478

Q40931689-67CB24CA-D830-4B8B-A5A1-9483502857D2

P50

Q40931689-135350B1-ABEF-4E15-89A7-269850CB192F

P577

Q40931689-30CA4D2E-4473-4B3C-A11C-2B01FF34E652

P5875

Q40931689-D82738E6-C5E3-4506-A1CD-1B9F59248D1B

P6179

Q40931689-A39C0620-795E-4C9F-AB01-65221CDB1815

P698

Q40931689-AEE95EF2-80D9-4226-80D0-FB2DB6B6DF54

P356

S10549-015-3430-3

P1433

Breast Cancer Research and Treatment

P1476

Loss of PTEN expression is ass ...... triple-negative breast cancer

@en

P2093

Abdul K Siraj

http://www.w3.org/2001/XMLSchema#string

Asma Tulbah

http://www.w3.org/2001/XMLSchema#string

Dahish Ajarim

http://www.w3.org/2001/XMLSchema#string

Fouad Al-Dayel

http://www.w3.org/2001/XMLSchema#string

Khawla S Al-Kuraya

http://www.w3.org/2001/XMLSchema#string

Sarita Prabhakaran

http://www.w3.org/2001/XMLSchema#string

Zeenath Jehan

http://www.w3.org/2001/XMLSchema#string

P2860

Optimal strategies for the treatment of metastatic triple-negative breast cancer with currently approved agents

PTEN, PIK3CA, p-AKT, and p-p70S6K status: association with trastuzumab response and survival in patients with HER2-positive metastatic breast cancer.

Global cancer statistics, 2012

Tissue microarrays for high-throughput molecular profiling of tumor specimens

Protein expression profile and prevalence pattern of the molecular classes of breast cancer--a Saudi population based study

Potential prognostic value of heat-shock protein 90 in the presence of phosphatidylinositol-3-kinase overexpression or loss of PTEN, in invasive breast cancers.

Triple negative breast tumors in African-American and Hispanic/Latina women are high in CD44+, low in CD24+, and have loss of PTEN.

Breast cancer subtypes and survival in patients with brain metastases

Immunotherapeutic approaches in triple-negative breast cancer: latest research and clinical prospects

Impact of PTEN protein expression on benefit from adjuvant trastuzumab in early-stage human epidermal growth factor receptor 2-positive breast cancer in the North Central Cancer Treatment Group N9831 trial.

P2888

s10549-015-3430-3

P304

541-553

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S10549-015-3430-3

http://www.w3.org/2001/XMLSchema#string

P407

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

151

http://www.w3.org/2001/XMLSchema#string

P50

P577

2015-05-16T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

276850593

http://www.w3.org/2001/XMLSchema#string

P6179

1045901149

http://www.w3.org/2001/XMLSchema#string

P698

25981902

http://www.w3.org/2001/XMLSchema#string